GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma

Noah A. Goldman, Ellen B. Katz, Alan S. Glenn, Richard H. Weldon, Joan G. Jones, Uticia Lynch, Melissa J. Fezzari, Carolyn D. Runowicz, Gary L. Goldberg, Maureen J. Charron

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Glucose is provided to cells by a family of glucose transport facilitators known as GLUTs. These transporters are expressed in a tissue specific manner and are overexpressed in many primary tumors of these tissues. Regulation of glucose transport facilitator expression has been demonstrated in endometrial tissue and endometrial adenocarcinoma. The following experiments were conducted to quantify and localize the expression of GLUT1 and GLUT8 in benign endometrium and compare this expression to endometrial cancer. Endometrial tissue samples were obtained from random hysterectomy specimens of patients with benign indications for surgery and endometrial cancer. Immunoblot and immunolocatization studies were performed using GLUT1 and GLUT8 specific antisera. Endometrial samples from 65 women who had undergone hysterectomy were examined (n=38 benign, n=27 malignant). A 44 and a 35.4 kDa immunoreacive species was demonstrated in endometrium and endometrial cancer for GLUT1 and GLUT8, respectively. Upregulation of GLUT1 expression was demonstrated with increasing grade of tumors (P<0.002). GLUT8 expression was increased in all tumor subtypes compared to atrophic endometrium (P<0.001). Apical localization by GLUT1 and GLUT8 was demonstrated in endometrial glands. GLUT1 and GLUT8 demonstrated diffuse intracellular localization in the cancer subtypes. GLUT1 and GLUT8 are expressed in both human endometrium and endometrial cancer. There appears to be a step-wise progression in GLUT1 and GLUT8 expression as tumor histopathology worsens. GLUT1 and GLUT8 may be important markers in tumor differentiation, as well as providing energy to rapidly dividing tumor cells.

Original languageEnglish (US)
Pages (from-to)1429-1436
Number of pages8
JournalModern Pathology
Volume19
Issue number11
DOIs
StatePublished - Nov 4 2006

Fingerprint

Endometrial Neoplasms
Endometrium
Adenocarcinoma
Neoplasms
Facilitative Glucose Transport Proteins
Hysterectomy
Tumor Biomarkers
Immune Sera
Up-Regulation
Glucose

Keywords

  • Glucose transport facilitators
  • Immunofluorescence
  • Uterine cancer

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Goldman, N. A., Katz, E. B., Glenn, A. S., Weldon, R. H., Jones, J. G., Lynch, U., ... Charron, M. J. (2006). GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Modern Pathology, 19(11), 1429-1436. https://doi.org/10.1038/modpathol.3800656

GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. / Goldman, Noah A.; Katz, Ellen B.; Glenn, Alan S.; Weldon, Richard H.; Jones, Joan G.; Lynch, Uticia; Fezzari, Melissa J.; Runowicz, Carolyn D.; Goldberg, Gary L.; Charron, Maureen J.

In: Modern Pathology, Vol. 19, No. 11, 04.11.2006, p. 1429-1436.

Research output: Contribution to journalArticle

Goldman, NA, Katz, EB, Glenn, AS, Weldon, RH, Jones, JG, Lynch, U, Fezzari, MJ, Runowicz, CD, Goldberg, GL & Charron, MJ 2006, 'GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma', Modern Pathology, vol. 19, no. 11, pp. 1429-1436. https://doi.org/10.1038/modpathol.3800656
Goldman NA, Katz EB, Glenn AS, Weldon RH, Jones JG, Lynch U et al. GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Modern Pathology. 2006 Nov 4;19(11):1429-1436. https://doi.org/10.1038/modpathol.3800656
Goldman, Noah A. ; Katz, Ellen B. ; Glenn, Alan S. ; Weldon, Richard H. ; Jones, Joan G. ; Lynch, Uticia ; Fezzari, Melissa J. ; Runowicz, Carolyn D. ; Goldberg, Gary L. ; Charron, Maureen J. / GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. In: Modern Pathology. 2006 ; Vol. 19, No. 11. pp. 1429-1436.
@article{b919dfa2d0f2450e8706f6c5167c9b89,
title = "GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma",
abstract = "Glucose is provided to cells by a family of glucose transport facilitators known as GLUTs. These transporters are expressed in a tissue specific manner and are overexpressed in many primary tumors of these tissues. Regulation of glucose transport facilitator expression has been demonstrated in endometrial tissue and endometrial adenocarcinoma. The following experiments were conducted to quantify and localize the expression of GLUT1 and GLUT8 in benign endometrium and compare this expression to endometrial cancer. Endometrial tissue samples were obtained from random hysterectomy specimens of patients with benign indications for surgery and endometrial cancer. Immunoblot and immunolocatization studies were performed using GLUT1 and GLUT8 specific antisera. Endometrial samples from 65 women who had undergone hysterectomy were examined (n=38 benign, n=27 malignant). A 44 and a 35.4 kDa immunoreacive species was demonstrated in endometrium and endometrial cancer for GLUT1 and GLUT8, respectively. Upregulation of GLUT1 expression was demonstrated with increasing grade of tumors (P<0.002). GLUT8 expression was increased in all tumor subtypes compared to atrophic endometrium (P<0.001). Apical localization by GLUT1 and GLUT8 was demonstrated in endometrial glands. GLUT1 and GLUT8 demonstrated diffuse intracellular localization in the cancer subtypes. GLUT1 and GLUT8 are expressed in both human endometrium and endometrial cancer. There appears to be a step-wise progression in GLUT1 and GLUT8 expression as tumor histopathology worsens. GLUT1 and GLUT8 may be important markers in tumor differentiation, as well as providing energy to rapidly dividing tumor cells.",
keywords = "Glucose transport facilitators, Immunofluorescence, Uterine cancer",
author = "Goldman, {Noah A.} and Katz, {Ellen B.} and Glenn, {Alan S.} and Weldon, {Richard H.} and Jones, {Joan G.} and Uticia Lynch and Fezzari, {Melissa J.} and Runowicz, {Carolyn D.} and Goldberg, {Gary L.} and Charron, {Maureen J.}",
year = "2006",
month = "11",
day = "4",
doi = "10.1038/modpathol.3800656",
language = "English (US)",
volume = "19",
pages = "1429--1436",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma

AU - Goldman, Noah A.

AU - Katz, Ellen B.

AU - Glenn, Alan S.

AU - Weldon, Richard H.

AU - Jones, Joan G.

AU - Lynch, Uticia

AU - Fezzari, Melissa J.

AU - Runowicz, Carolyn D.

AU - Goldberg, Gary L.

AU - Charron, Maureen J.

PY - 2006/11/4

Y1 - 2006/11/4

N2 - Glucose is provided to cells by a family of glucose transport facilitators known as GLUTs. These transporters are expressed in a tissue specific manner and are overexpressed in many primary tumors of these tissues. Regulation of glucose transport facilitator expression has been demonstrated in endometrial tissue and endometrial adenocarcinoma. The following experiments were conducted to quantify and localize the expression of GLUT1 and GLUT8 in benign endometrium and compare this expression to endometrial cancer. Endometrial tissue samples were obtained from random hysterectomy specimens of patients with benign indications for surgery and endometrial cancer. Immunoblot and immunolocatization studies were performed using GLUT1 and GLUT8 specific antisera. Endometrial samples from 65 women who had undergone hysterectomy were examined (n=38 benign, n=27 malignant). A 44 and a 35.4 kDa immunoreacive species was demonstrated in endometrium and endometrial cancer for GLUT1 and GLUT8, respectively. Upregulation of GLUT1 expression was demonstrated with increasing grade of tumors (P<0.002). GLUT8 expression was increased in all tumor subtypes compared to atrophic endometrium (P<0.001). Apical localization by GLUT1 and GLUT8 was demonstrated in endometrial glands. GLUT1 and GLUT8 demonstrated diffuse intracellular localization in the cancer subtypes. GLUT1 and GLUT8 are expressed in both human endometrium and endometrial cancer. There appears to be a step-wise progression in GLUT1 and GLUT8 expression as tumor histopathology worsens. GLUT1 and GLUT8 may be important markers in tumor differentiation, as well as providing energy to rapidly dividing tumor cells.

AB - Glucose is provided to cells by a family of glucose transport facilitators known as GLUTs. These transporters are expressed in a tissue specific manner and are overexpressed in many primary tumors of these tissues. Regulation of glucose transport facilitator expression has been demonstrated in endometrial tissue and endometrial adenocarcinoma. The following experiments were conducted to quantify and localize the expression of GLUT1 and GLUT8 in benign endometrium and compare this expression to endometrial cancer. Endometrial tissue samples were obtained from random hysterectomy specimens of patients with benign indications for surgery and endometrial cancer. Immunoblot and immunolocatization studies were performed using GLUT1 and GLUT8 specific antisera. Endometrial samples from 65 women who had undergone hysterectomy were examined (n=38 benign, n=27 malignant). A 44 and a 35.4 kDa immunoreacive species was demonstrated in endometrium and endometrial cancer for GLUT1 and GLUT8, respectively. Upregulation of GLUT1 expression was demonstrated with increasing grade of tumors (P<0.002). GLUT8 expression was increased in all tumor subtypes compared to atrophic endometrium (P<0.001). Apical localization by GLUT1 and GLUT8 was demonstrated in endometrial glands. GLUT1 and GLUT8 demonstrated diffuse intracellular localization in the cancer subtypes. GLUT1 and GLUT8 are expressed in both human endometrium and endometrial cancer. There appears to be a step-wise progression in GLUT1 and GLUT8 expression as tumor histopathology worsens. GLUT1 and GLUT8 may be important markers in tumor differentiation, as well as providing energy to rapidly dividing tumor cells.

KW - Glucose transport facilitators

KW - Immunofluorescence

KW - Uterine cancer

UR - http://www.scopus.com/inward/record.url?scp=33750286742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750286742&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800656

DO - 10.1038/modpathol.3800656

M3 - Article

VL - 19

SP - 1429

EP - 1436

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 11

ER -